Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

PERRIGO COMPANY PLC

(PRGO)
  Report
 SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   Delayed Quote. Delayed Nyse
06/08/2021 06/09/2021 06/10/2021 06/11/2021 06/14/2021 Date
47.03(c) 47.07(c) 48.87(c) 47.73(c) 47.73 Last
798 014 1 312 688 1 220 957 1 153 215 1 249 410 Volume
+0.62% +0.09% +3.82% -2.33% 0.00% Change
More quotes
Financials (USD)
Sales 2021 4 218 M - -
Net income 2021 194 M - -
Net Debt 2021 1 057 M - -
P/E ratio 2021 -367x
Yield 2021 2,11%
Sales 2022 4 350 M - -
Net income 2022 235 M - -
Net Debt 2022 751 M - -
P/E ratio 2022 104x
Yield 2022 2,32%
Capitalization 6 374 M 6 374 M -
EV / Sales 2021 1,76x
EV / Sales 2022 1,64x
Nbr of Employees 11 500
Free-Float 98,8%
More Financials
Company
Perrigo Co. Plc engages in providing over-the-counter (OTC) self-care and wellness solutions. Its solutions enhance individual well-being by enabling consumers to proactively prevent or treat conditions that can be self-managed. The Company operates through three segments: Consumer Self-Care Americas, Consumer Self-Care International and Prescription Pharmaceuticals. The Consumer Self-Care Americas segment comprises... 
Sector
Pharmaceuticals
Calendar
06/16 | 09:05amPresentation
More about the company
Ratings of Perrigo Company plc
Trading Rating : 
Investor Rating : 
ESG Refinitiv : 
C+
More Ratings
All news about PERRIGO COMPANY PLC
06/03PERRIGO COMPANY PLC : Ex-dividend day for
FA
05/21PERRIGO  : To Present Virtually At Upcoming Consumer Investor Conferences
PR
05/18PERRIGO  : to Sell Mexico, Brazil OTC Businesses to Advent International
MT
05/17Luxury yacht maker Italian Sea Group secures Armani's backing in IPO
RE
05/14PERRIGO CO PLC  : Submission of Matters to a Vote of Security Holders (form 8-K)
AQ
05/13PERRIGO  : Says Irish Revenue Rejects Offer to Settle Disputed 1.64 Billion Euro..
MT
05/12PERRIGO  : MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESUL..
AQ
05/12PERRIGO  : REPORTS FIRST QUARTER 2021 FINANCIAL RESULTS FROM CONTINUING OPERATIO..
PU
05/11INSIDER TRENDS : Insider at Perrigo Company Exercises Options in Mist of 90-Day ..
MT
05/11INSIDER TRENDS : Perrigo Company Insider Exercises Option/Derivative Security to..
MT
05/11INSIDER TRENDS : Insider at Perrigo Company Acquires Stock Via Conversion of Opt..
MT
05/11INSIDER TRENDS : Perrigo Company Insider Converts Option/Derivative Security Sel..
MT
05/11INSIDER TRENDS : Insider at Perrigo Company Acquires Stock Via Option/Derivative..
MT
05/11PERRIGO  : First Quarter 2021 Financial Results
PU
05/11PERRIGO  : Fiscal Q1 Earnings, Revenue Drop
MT
More news
News in other languages on PERRIGO COMPANY PLC
05/10L'agenda di domani
05/10L'agenda della settimana
05/07L'agenda della prossima settimana
04/07DGAP-HV : Fresenius Medical Care AG & Co. KGaA: -4-
04/07DGAP-HV : Fresenius Medical Care AG & Co. KGaA: -2-
More news
Analyst Recommendations on PERRIGO COMPANY PLC
More recommendations
Chart PERRIGO COMPANY PLC
Duration : Period :
Perrigo Company plc Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends PERRIGO COMPANY PLC
Short TermMid-TermLong Term
TrendsBullishBullishBearish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus HOLD
Number of Analysts 8
Average target price 50,83 $
Last Close Price 47,73 $
Spread / Highest target 34,1%
Spread / Average Target 6,50%
Spread / Lowest Target -5,72%
EPS Revisions
Managers and Directors
NameTitle
Murray S. Kessler President, Chief Executive Officer & Director
Raymond P. Silcock CFO, Principal Accounting Officer & Executive VP
Rolf Allan Classon Chairman
Thomas M. Farrington Chief Information Officer & Executive VP
Grainne Quinn Chief Medical Officer & Executive Vice President
Sector and Competitors
1st jan.Capitalization (M$)
PERRIGO COMPANY PLC6.73%6 374
JOHNSON & JOHNSON4.82%434 405
ROCHE HOLDING AG10.68%328 612
PFIZER, INC.9.07%224 747
NOVARTIS AG-0.39%208 035
ABBVIE INC.7.72%203 857